Upstate Clinical Research Associates

Williamsville, New York 14221

3 studies enrolling now · 37 studies all time

What they study most

Acute Migraine, Acute Pain, Arthritis, Rheumatoid, Back Pain, Back Pain Lower Back Chronic, Back Spasm Upper Back, Back Strain, Chronic Low Back Pain, Chronic Lower Back Pain, Chronic Migraine, Chronic Noncancer Pain, Chronic Nonmalignant and Nonneuropathic Pain

Studies at this site

• A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine — Recruiting now
• A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults — Recruiting now
• A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats — Completed
• Comparison of a Single RTX-GRT7039 and Placebo Intra-articular Injection for Pain Associated With Osteoarthritis of the Knee — Completed
• Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles — Completed
• A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine — Completed
• Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain — Completed
• A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine — Completed
• Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain — Completed
• Tolperisone in Acute Muscle Spasm of the Back — Completed
• Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain — Completed
• A Study to Assess Efficacy and Safety of GLPG1972/S201086 in Participants With Knee Osteoarthritis — Completed
• A Study of Tanezumab in Adults With Chronic Low Back Pain — Completed
• A Long Term Study of the Safety of Tanezumab When Administered By Subcutaneous Injections — Stopped early
• Long Term Safety Study of Tanezumab in Chronic Low Back Pain — Stopped early
• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed
• MLE4901 vs. Placebo for the Treatment of PCOS — Stopped early
• AMZ001 for the Treatment of Knee Osteoarthritis Symptoms — Completed
• Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period. — Completed
• Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain — Completed
• Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone — Completed
• Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone — Completed
• A Study of LY2951742 in Participants With Mild to Moderate Osteoarthritis Knee Pain — Stopped early
• An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine — Completed
• A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms — Completed
• Long-term Open-Label Safety Study to Evaluate EN3409 — Completed
• Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 202 — Completed
• Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) in Patients Who Require Opioid Treatment for an Extended Period of Time — Completed
• Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) for Relief of Moderate to Severe Pain in Patients With Osteoarthritis or Low Back Pain Who Require Opioid Treatment for an Extended Period of Time — Completed
• Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects — Completed
• Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain — Completed
• Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301 — Stopped early
• A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine — Completed
• A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis (SHaRCS) — Completed
• Safety and Efficacy Study of MRE0094 to Treat Chronic, Neuropathic, Diabetic Foot Ulcers — Completed
• Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for Breakthrough Pain in Patients With Chronic Pain — Completed